###begin article-title 0
DJ-1 Modulates alpha-Synuclein Aggregation State in a Cellular Model of Oxidative Stress: Relevance for Parkinson's Disease and Involvement of HSP70
###end article-title 0
###begin p 1
Conceived and designed the experiments: DA. Performed the experiments: SB RR LP FP MP. Analyzed the data: GF DA SB. Contributed reagents/materials/analysis tools: AN. Wrote the paper: DA.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 398 414 390 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">substantia nigra</italic>
###xml 426 434 <span type="species:ncbi:9606">patients</span>
Parkinson's disease (PD) is a neurodegenerative pathology whose molecular etiopathogenesis is not known. Novel contributions have come from familial forms of PD caused by alterations in genes with apparently unrelated physiological functions. The gene coding for alpha-synuclein (alpha-syn) (PARK1) has been investigated as alpha-syn is located in Lewy bodies (LB), intraneuronal inclusions in the substantia nigra (SN) of PD patients. A-syn has neuroprotective chaperone-like and antioxidant functions and is involved in dopamine storage and release. DJ-1 (PARK7), another family-PD-linked gene causing an autosomal recessive form of the pathology, shows antioxidant and chaperone-like activities too.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 211 219 203 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 635 636 611 612 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 637 638 613 614 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 255 260 <span type="species:ncbi:9606">human</span>
The present study addressed the question whether alpha-syn and DJ-1 interact functionally, with a view to finding some mechanism linking DJ-1 inactivation and alpha-syn aggregation and toxicity. We developed an in vitro model of alpha-syn toxicity in the human neuroblastoma cell line SK-N-BE, influencing DJ-1 and alpha-syn intracellular concentrations by exogenous addition of the fusion proteins TAT-alpha-syn and TAT-DJ-1; DJ-1 was inactivated by the siRNA method. On a micromolar scale TAT-alpha-syn aggregated and triggered neurotoxicity, while on the nanomolar scale it was neuroprotective against oxidative stress (induced by H2O2 or 6-hydroxydopamine). TAT-DJ-1 increased the expression of HSP70, while DJ-1 silencing made SK-N-BE cells more susceptible to oxidative challenge, rendering TAT-alpha-syn neurotoxic at nanomolar scale, with the appearance of TAT-alpha-syn aggregates.
###end p 5
###begin title 6
Conclusion/Significance
###end title 6
###begin p 7
DJ-1 inactivation may thus promote alpha-syn aggregation and the related toxicity, and in this model HSP70 is involved in the antioxidant response and in the regulation of alpha-syn fibril formation.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 133 136 133 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-DiMonte1">[1]</xref>
###xml 138 141 138 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Fahn1">[2]</xref>
###xml 278 281 278 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Hardy1">[3]</xref>
###xml 282 285 282 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Klein1">[5]</xref>
###xml 501 506 501 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">alias</italic>
###xml 583 588 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">alias</italic>
###xml 709 712 701 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Polymeropoulos1">[6]</xref>
###xml 713 716 705 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Tang1">[9]</xref>
Parkinson's disease (PD) is a neurodegenerative, multifactorial movement disorder affecting about 3% of the population over 65 years [1], [2]. To date, six different casual genes linked to rare familiar forms of PD have been identified, with few evident functional interactions [3]-[5]. Consequently, a major question is the relationship between these proteins whose alteration leads ultimately to a similar pathology. Genetic modifications in the proteins coded by the family-PD-linked genes PARK-1 [alias alpha-synuclein (alpha-syn); GenBank: NM_000345; OMIM: #168600] and PARK-7 (alias DJ-1; GenBank: NM_007262; OMIM: #606324) cause respectively an autosomal dominant and an autosomal recessive form of PD [6]-[9].
###end p 9
###begin p 10
###xml 101 105 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Jellinger1">[10]</xref>
###xml 309 313 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Volles1">[11]</xref>
###xml 315 319 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Klucken1">[12]</xref>
###xml 414 418 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Hashimoto1">[13]</xref>
###xml 420 424 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Fleming1">[14]</xref>
###xml 489 493 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Singleton1">[15]</xref>
###xml 495 499 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Nishioka1">[16]</xref>
###xml 752 756 740 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Lykkebo1">[17]</xref>
###xml 757 761 745 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Ahn1">[19]</xref>
###xml 897 901 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Chandra1">[20]</xref>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
A-syn physiologic function is unclear, but the protein is present in Lewy bodies (LB), a PD hallmark [10]. An alpha-syn-dependent etiopathologic hypothesis states that in PD alpha-syn is able to aggregate and gain a toxic function, even if the noxious aggregated form (protofibrillar or fibrillar) is debated [11], [12]. Transgenic models developed to support this hypothesis resulted in mild to severe phenotypes [13], [14]. A-syn gene multiplication has been associated with familial PD [15], [16]. Other data support an alternative scenario where alpha-syn aggregation prevents the protein performing its physiological neuroprotective functions that deal with chaperone-like activity, dopamine homeostasis and correct synaptic vesicular trafficking [17]-[19]. A-syn null mice did not show a severe phenotype, suggesting that loss of function alone is not sufficient to explain the pathogenesis [20].
###end p 10
###begin p 11
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Bonifati1">[21]</xref>
###xml 106 110 106 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Hedrich1">[22]</xref>
###xml 296 300 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Eerola1">[23]</xref>
###xml 302 306 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Choi1">[24]</xref>
###xml 391 395 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Menzies1">[25]</xref>
###xml 397 401 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Yang1">[26]</xref>
###xml 429 433 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Shendelman1">[27]</xref>
###xml 435 439 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Zhou1">[28]</xref>
###xml 481 485 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Ved1">[29]</xref>
###xml 487 491 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Zhang1">[30]</xref>
###xml 517 521 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Goldberg1">[31]</xref>
###xml 523 527 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Zhong1">[32]</xref>
DJ-1 mutations are single-nucleotide substitutions or deletions leading to a non-functional protein [21], [22]. DJ-1 alterations are more frequent than alpha-syn mutations; consequently, DJ-1 has been evaluated as a genetic predisposing factor for sporadic PD though with mainly negative results [23], [24]. Information on DJ-1 function in the nervous system deals with antioxidant activity [25], [26], chaperone-like properties [27], [28], involvement in mitochondrial physiology [29], [30] and dopamine homeostasis [31], [32].
###end p 11
###begin p 12
###xml 217 221 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Zhou2">[33]</xref>
###xml 274 281 258 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 286 294 270 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 294 298 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Huang1">[34]</xref>
###xml 300 304 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Klucken2">[35]</xref>
###xml 394 398 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Albani1">[36]</xref>
The interaction between alpha-syn and DJ-1 has been explored in cellular models of alpha-syn overexpression, suggesting that DJ-1 is involved in preventing alpha-syn toxicity by induction of HSP70 (GenBank NM_005345) [33]. HSP70 was also shown to prevent alpha-syn toxicity in vivo and in vitro[34], [35] and it was suggested that alpha-syn neuroprotective activity depended on HSP70 induction [36].
###end p 12
###begin p 13
###xml 76 84 72 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 118 123 <span type="species:ncbi:9606">human</span>
To clarify the relationship among alpha-syn, DJ-1 and HSP70 we developed an in vitro model of oxidative stress in the human neuroblastoma cell line SK-N-BE, where we transiently altered the alpha-syn and DJ-1 concentrations by adding TAT-fused proteins and by the siRNA approach.
###end p 13
###begin title 14
Materials and Methods
###end title 14
###begin title 15
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human neuroblastoma SK-N-BE cells
###end title 15
###begin p 16
###xml 45 46 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 85 91 <span type="species:ncbi:9913">bovine</span>
Cells were cultured at 37degreesC, with 5% CO2 in D-MEM supplemented with 10% foetal bovine serum (FBS), 2 mM L-glutamine, 100 IU/mL penicillin and 100 microg/mL streptomycin (Invitrogen, Carlsbad-CA, USA), in a humidified atmosphere.
###end p 16
###begin title 17
Alpha-synuclein and DJ-1: cloning and TAT-fused proteins generation
###end title 17
###begin p 18
###xml 463 470 455 462 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YGRKKRR</underline>
###xml 644 648 636 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Dietz1">[37]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
###xml 416 421 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human alpha-syn full-length cDNA and human DJ-1 full-length cDNA were cloned starting from a human brain cDNA library (Clontech, Palo Alto-CA, USA) by RACE-PCR. The amplified cDNAs were then cloned into pRSET expression vectors (Invitrogen, Carlsbad-CA, USA) and fully sequenced. To generate the fusion proteins TAT-alpha-syn and TAT-DJ-1 the sequence coding for a peptide containing the translocation domain of the HIV-1 protein TAT (underlined) (MRGSHHHHHHGMARGYGRKKRRPASPGAS) was inserted in frame before the N-terminal of the corresponding cDNA. The fusion proteins were then expressed and purified adapting standard recombinant techniques [37].
###end p 18
###begin title 19
Oxidative stress challenge and TAT-fused protein treatment
###end title 19
###begin p 20
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 178 179 178 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 180 181 180 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 255 256 255 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 257 258 257 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 886 887 870 871 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 888 889 872 873 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
To challenge SK-N-BE cells with oxidative stress, 60x103 cells were seeded in a 96-well plate and incubated overnight. The day after, the medium was changed, a freshly prepared H2O2 dilution (or 6-hydroxydopamine [6-OHDA]) was added (final concentration H2O2 75 microM; 6-OHDA 50 microM), and the cells were incubated for 24 h. Viable cells were estimated by erythrosine-dye exclusion assay or lysed in the presence of a broad-range protease inhibitor cocktail to obtain a total protein extract. To perform erythrosine-dye exclusion assay, cells were harvested by trypsinization and resuspended in complete D-MEM medium. An aliquot (10 microL) was stained 1:1 (vol/vol) with a 0.05% erythrosine B-dye solution in PBS and viable cells (uncoloured) were counted using a cell counting chamber. To verify the protective action of alpha-syn (or DJ-1) against oxidative injury, 2-4 h before H2O2 (or 6-OHDA) was added, the cells were incubated with TAT-alpha-syn 0.5 microM (or TAT-DJ-1 3 microM) in order to assure that the media contained the TAT-fused proteins during the oxidative challenge. To trigger TAT-alpha-syn toxicity, cells were incubated with TAT-alpha-syn 3 microM for 24 h, then viability was assessed by erythrosine-dye exclusion assay or cells were lysed as described above.
###end p 20
###begin title 21
Thioflavin-T binding assay for detection of amyloid aggregates
###end title 21
###begin p 22
SK-N-BE cells were cultured on plastic chamber slides (Nalge Nunc International-NY, USA), and treated as previously reported, with TAT-alpha-syn (0.5-3 microM) for 24-48 h. Then, they were fixed with 2% paraformaldehyde and incubated 8 min with 0.05% thioflavin-T solution in PBS. After washing twice with PBS, fluorescence emission was monitored by a fluorescence microscope (Olympus Corporation, Tokyo, Japan) coupled to a digital camera (Olympus Corporation, Tokyo, Japan).
###end p 22
###begin title 23
Western blotting
###end title 23
###begin p 24
###xml 266 277 <span type="species:ncbi:3704">horseradish</span>
About 25 microg of total protein extract was subjected to gradient SDS-PAGE electrophoresis (5-12%) and transferred to a nitrocellulose membrane (BioRad Laboratories, Hercules-CA, USA). The membrane was incubated overnight with a primary antibody, for 1 hour with a horseradish peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology, Santa Cruz-CA, USA) and ECL-detected (GE Healthcare, Piscataway-NJ, USA). The resulting impressed film was quantified using a digital image analyser (Syngene Corporation, Cambridge, UK).
###end p 24
###begin title 25
Immunocytochemistry
###end title 25
###begin p 26
###xml 5 6 5 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 249 254 <span type="species:ncbi:9796">horse</span>
30x103 SK-N-BE cells were cultured on plastic chamber slide, fixed with 4% paraformaldehyde and permeabilized using 0.5% Triton-X 100, 0.2% FCS in PBS. Then, they were incubated overnight at 4degreesC with a primary antibody diluted 1:100 in PBS+1% horse serum (HS), followed by a FITC-conjugated secondary antibody (Jackson Immuno Laboratories, West Grove-PA, USA) diluted 1:200 in PBS+1% HS. Cells were then analyzed with a fluorescence microscope coupled to a digital camera (Olympus Corporation, Tokyo, Japan).
###end p 26
###begin title 27
RNA interference
###end title 27
###begin p 28
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 304 332 300 328 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGG ACCAUAUGAUGUGGUGtt-3&#8242;</named-content>
###xml 345 372 341 368 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACCACAUCAUAUGGUCCCtc-3&#8242;</named-content>
###xml 389 416 385 412 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGAGCAGGAAAACCGGAAGtt-3&#8242;</named-content>
###xml 429 455 425 451 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CUUCCGGUUUUCCUGCUCCtt-3</named-content>
###xml 941 946 <span type="species:ncbi:9606">human</span>
RNA interference was performed as follows: 80x103 SK-N-BE cells were seeded in a 24-well plate and grown overnight. The next day, the medium was replaced with 250 microL of fresh complete medium and two pre-designed double-strand small-interfering RNAs (siRNA) against DJ-1 mRNA sequence (siRNA-A sense: 5'-GGG ACCAUAUGAUGUGGUGtt-3'; antisense: 5'-CACCACAUCAUAUGGUCCCtc-3'. siRNA-B sense: 5'-GGAGCAGGAAAACCGGAAGtt-3'; antisense: 5'-CUUCCGGUUUUCCUGCUCCtt-3) (Ambion, Austin-TX, USA) were added singularly in 50 microL serum-free Optimem (Invitrogen, Carlsbad-CA) at 100 nM final concentration using as vehicle SilentFect liposome formulation (BioRad Laboratories, Hercules-CA) for 24-96 h, without any other medium change, to achieve DJ-1 downregulation. To prove specific DJ-1 silencing, also a negative control siRNA was used (CT-), comprised of a 19 bp scrambled sequence with 3' dT overhangs that has no significant homology to any known human gene sequence (Ambion, Austin-TX, USA). Cell viability was then assessed by erythrosine-dye exclusion assay or cells were lysed in the presence of a broad-range protease inhibitor to obtain a total protein extract.
###end p 28
###begin title 29
Semiquantitative RT-PCR
###end title 29
###begin p 30
###xml 203 238 203 238 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTT GAC AAC AGG CTG GTG AAC C-3&#8242;</named-content>
###xml 255 290 255 290 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTG AAG ATC TGC GTC TGG TTG G-3&#8242;</named-content>
###xml 312 344 312 344 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGC AGA AGG GGT CCT GGT GA-3&#8242;</named-content>
###xml 366 403 366 403 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAG CTC CTT CTT CTG CTC CGG GGT-3&#8242;</named-content>
Semiquantitative RT-PCR was performed starting from 100 ng of DNA-free total RNA extracted from SK-N-BE cells with a commercial kit (Qiagen, Valencia-CA, USA) using the following primers: HSP70 forward: 5'-TTT GAC AAC AGG CTG GTG AAC C-3'; HSP70 reverse: 5'-GTG AAG ATC TGC GTC TGG TTG G-3'; aldolase-A forward: 5'-CGC AGA AGG GGT CCT GGT GA-3'; aldolase-A reverse: 5'-CAG CTC CTT CTT CTG CTC CGG GGT-3'. The resulting PCR products were loaded and quantified on a capillary electrophoresis unit (Agilent Technologies, Palo Alto-CA, USA) in comparison to a standard internal marker.
###end p 30
###begin title 31
Antibodies
###end title 31
###begin p 32
The following primary antibodies were used to run immunoblotting or immunocytochemistry: anti alpha-syn monoclonal antibody (Transduction Laboratories, Lexington-KY, USA); anti DJ-1 polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz-CA. USA); anti alpha-tubulin monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz-CA, USA) and anti HSP70 polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz-CA, USA).
###end p 32
###begin title 33
Chemicals and reagents
###end title 33
###begin p 34
All chemicals were of analytical grade. Where not stated otherwise, reagents were from Sigma (Sigma Aldrich, St Louis-MO, USA).
###end p 34
###begin title 35
Statistical analysis
###end title 35
###begin p 36
###xml 183 191 183 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
All experiments were run at least three times. Statistics was analyzed using the program StatView ver 5.0. One-way ANOVA (or two-way ANOVA) was used, followed by Dunnett's or Tukey's post-hoc test. The significance limit was set at p = 0.05.
###end p 36
###begin title 37
Results
###end title 37
###begin title 38
TAT-alpha-syn and TAT-DJ-1 prevent oxidative stress in SK-N-BE cells
###end title 38
###begin p 39
###xml 31 32 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 33 34 33 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 172 183 172 183 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A&#8211;B</bold>
###xml 172 183 172 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g001"><bold>Figure 1A&#8211;B</bold></xref>
###xml 245 246 241 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 247 248 243 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
SK-N-BE cells were exposed to H2O2 or 6-OHDA for 24 h and neurotoxicity was assessed. To establish the optimal experimental dosage, we first plotted a dose-response curve [Figure 1A-B]. We decided to run the ensuing experiments using 75 microM H2O2 or 50 microM 6-OHDA, that reduced cell viability by about 50%.
###end p 39
###begin title 40
TAT-alpha-syn and TAT-DJ-1 prevent oxidative stress in SK-N-BE cells.
###end title 40
###begin p 41
###xml 69 70 69 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 71 72 71 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 351 352 347 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 353 354 349 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 377 385 373 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 1103 1104 1063 1064 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1105 1106 1065 1066 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1127 1135 1087 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 1424 1432 1368 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
(A) Dose-response pattern of the toxic effect of hydrogen peroxide (H2O2) in SK-N-BE cells. (B) Dose-response curve of 6-hydroxydopamine (6-OHDA) toxicity in SK-N-BE cells. Cells were plated and challenged by oxidative stress for 24 h and cell viability was assessed by erythrosine-dye exclusion assay; *p<0.05; ***p<0.001 vs control group (0 microM H2O2 or 6-OHDA), Dunnett's post-hoc test. (C) Western blot assessing TAT-alpha-syn 0.5 microM and TAT-DJ-1 3 microM availability inside SK-N-BE cells. Cells were plated and incubated in presence of TAT-alpha-syn or TAT-DJ-1 for the reported time intervals. To demonstrate equal gel loading, alpha-tubulin immunoreactivity is also presented. (D) Protective effect of TAT-delivered alpha-syn and (E) TAT-delivered DJ-1 against oxidative stress. Cells were incubated with increasing amounts of TAT-alpha-syn or TAT-DJ-1 2-4 h before the toxic treatment and 24 h later cell viability was assessed by erythrosine-dye exclusion assay; *p<0.05; **p<0.01 vs control group at the same TAT-alpha-syn or TAT-DJ-1 concentration (CT, corresponding also to 0 microM H2O2 or 6-OHDA), Tukey's post-hoc test. (F) Toxicity of micromolar amounts of TAT-alpha-syn. Cells were incubated with increasing concentrations of TAT-alpha-syn for 24 h and cell viability was assessed by erythrosine-dye exclusion assay. **p<0.01 vs control group (CT, corresponding to 0 microM TAT-alpha-syn), Dunnett's post-hoc test. (G) Amyloid aggregation of TAT-alpha-syn 3 microM was detected by thioflavin-T staining after 24 h incubation; a) SK-N-BE control cells; b) SK-N-BE cells incubated with TAT-alpha-syn 3 microM. The arrows indicate intracellular thioflavin-T-positive inclusions (magnification 20X).
###end p 41
###begin p 42
###xml 779 788 747 756 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 779 788 747 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g001"><bold>Figure 1C</bold></xref>
To finely tune the alpha-syn or DJ-1 intracellular concentration, we incubated cells with the fusion proteins TAT-alpha-syn and TAT-DJ-1. First we used Western blotting to plot the kinetics of TAT-alpha-syn and TAT-DJ-1 availability inside cells. The basal level of endogenous alpha-syn in SK-N-BE cell was negligible (0h lane), while TAT-alpha-syn 0.5 microM fusion protein was detectable from 4 h after addition to the medium, migrated as a doublet around 21KDa and even if its total amount decreased over time it was still present 48h after treatment. At difference from alpha-syn, SK-N-BE expressed DJ-1 at basal level (0h lane) but after TAT-DJ-1 3 microM addition a stronger immunoreactive band was detectable starting from 2h and its level kept almost unchanged till 48h [Figure 1C].
###end p 42
###begin p 43
###xml 150 159 146 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 150 159 146 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g001"><bold>Figure 1D</bold></xref>
###xml 441 442 425 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 443 444 427 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 471 480 455 464 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1E</bold>
###xml 471 480 455 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g001"><bold>Figure 1E</bold></xref>
###xml 598 599 578 579 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 600 601 580 581 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1116 1128 1080 1092 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1 F&#8211;G</bold>
###xml 1116 1128 1080 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g001"><bold>Figure 1 F&#8211;G</bold></xref>
Afterwards, we verified the protective effect of TAT-alpha-syn or TAT-DJ-1 against oxidative challenge, performing a dose-response curve. As shown in Figure 1D, TAT-alpha-syn protection started from 0.1 microM in comparison to untreated cells, but the optimal protective concentration was set at 0.5 microM, where we observed an almost complete prevention of oxidative stress-induced toxicity. TAT-DJ-1 too was neuroprotective against both H2O2 and 6-OHDA neurotoxicity [Figure 1E]. Viability increased starting from 1 microM for 6-OHDA treated cells, and the optimal protective dose against both H2O2 and 6-OHDA was set at 3 microM, where we found a survival rate that was not statistically different from control. Increasing further the TAT-DJ-1 concentration did not improve survival rate, even if no toxicity was detectable up to 5 microM (data not shown). We have also tried to further increase TAT-alpha-syn concentration but at doses higher than 1 microM it reduced cell viability and caused a thioflavin-T positive reaction, suggesting the appearance of intracellular aggregated forms of the fusion protein [Figure 1 F-G].
###end p 43
###begin title 44
DJ-1 downregulation by siRNA increased SK-N-BE susceptibility to oxidative challenge
###end title 44
###begin p 45
###xml 169 178 169 178 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 169 178 169 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g002"><bold>Figure 2A</bold></xref>
In order to verify how much DJ-1 protected SK-N-BE cells from oxidative damage, we downregulated endogenous DJ-1 expression by small-interfering RNA (siRNA) technology. Figure 2A shows a preliminary DJ-1 silencing experiment assessed by Western blotting, using two independent DJ-1-targeted siRNAs (siRNA-A and siRNA-B), 20 or 100 nM final concentration each, for 72 h. Both siRNAs achieved DJ-1 downregulation, but siRNA-B 100nM was the most effective, as confirmed by blot quantification [DJ-1/alpha-tubulin optical density (OD) ratio in control (mean+/-SD, n = 3): 1.1+/-0.1; DJ-1/alpha-tubulin OD ratio (mean+/-SD, n = 3) for siRNA-A 100 nM: 0.5+/-0.1; DJ-1/alpha-tubulin OD ratio for siRNA-B 100 nM (mean+/-SD, n = 3): 0.4+/-0.1, p<0.001 vs control, Tukey's test]. Consequently, for the ensuing silencing experiments we decided to use siRNA-B at 100 nM.
###end p 45
###begin title 46
DJ-1 downregulation by siRNA increases SK-N-BE susceptibility to oxidative challenge.
###end title 46
###begin p 47
###xml 900 901 897 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1006 1014 1003 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 1666 1667 1645 1646 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1668 1669 1647 1648 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1694 1702 1673 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 2268 2269 2225 2226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2270 2271 2227 2228 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2297 2305 2254 2262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
(A) Preliminary Western blotting experiment aimed at modulating DJ-1 expression by siRNA. Two different siRNAs were tested by exposing SK-N-BE cells to 20 and 100 nM siRNA for 72 h. Each blot lane is representative of a triplicate assay in the same experiment (B) Western blotting assessing the specificity of the proposed silencing method. SK-N-BE cells were exposed for 72 h to beta-actin targeted pre-designed siRNA and to a siRNA negative control (CT-) with no sequence similarity to DJ-1 mRNA. Each blot lane is representative of a triplicate assay in the same experiment. (C) Silencing DJ-1 expression by siRNA. Cells were incubated with 100 nM pre-annealed siRNA targeted to DJ-1. Starting 24 h after transfection, DJ-1 protein level was assessed by Western blotting and quantified by a digital image analyzer. The quantification (D) is representative of one of three independent experiments (n = 3 for each point); *p<0.05; **p<0.01 vs control group (siRNA lipid vehicle) at the same time, Tukey's post-hoc test. (E) DJ-1 silencing was also independently assessed by immunocytochemisty: a) SK-N-BE control cells exposed for 72 h to siRNA lipid vehicle alone (magnification 10X); b) SK-N-BE cells incubated for 72 h with 100nM DJ-1 siRNA (magnification 10X). (F) DJ-1 downregulation increases cell susceptibility to oxidative stress. Cells were silenced for DJ-1 expression for 72 h, then the oxidative stimuli were added for a further 24 h. Cell viability was assessed by erythrosine-dye exclusion assay. CT-: siRNA negative control; *p<0.05; **p<0.01 vs control group (siRNA lipid vehicle alone); degreesp<0.05; degreesdegreesp<0.01 vs siRNA lipid vehicle+H2O2 or 6-OHDA alone; Tukey' post-hoc test. (G) Specific effect of DJ-1 on oxidative stress response. Cells were silenced for DJ-1 expression for 72 h, then TAT-DJ-1 3 microM or a recombinant DJ-1 at the same concentration (rDJ-1, a purified form of DJ-1 without the TAT sequence) was added 2 h before the oxidative challenge. After 24 h, cell viability was assessed by erythrosine-dye exclusion assay. DJ-1 silencing in the same experiment was confirmed by Western blotting (not shown); **p<0.01 vs control group (siRNA lipid vehicle alone), degreesp<0.05; degreesdegreesp<0.01 vs siRNA lipid vehicle+H2O2 or 6-OHDA alone; Tukey's post-hoc test.
###end p 47
###begin p 48
###xml 474 483 444 453 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2B</bold>
###xml 474 483 444 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g002"><bold>Figure 2B</bold></xref>
We also performed a specificity control experiment using a beta-actin targeted-siRNA that was unable to affect DJ-1 expression, so did a siRNA negative control (CT-) with no sequence homology to DJ-1 mRNA [Western blot quantification: DJ-1/alpha-tubulin OD ratio for control (mean+/-SD, n = 3): 1.0+/-0.1; DJ-1/alpha-tubulin OD ratio (mean+/-SD, n = 3) for beta-actin siRNA 100 nM: 1.0+/-0.1; DJ-1/alpha-tubulin OD ratio (mean+/-SD, n = 3) for CT- siRNA 100 nM: 0.9+/-0.1] [Figure 2B]. The silencing treatment using the lipid vehicle was not toxic to cells, with no statistically significant reduction in cellular viability in comparison to untreated cells (data not shown).
###end p 48
###begin p 49
###xml 105 114 105 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2C</bold>
###xml 105 114 105 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g002"><bold>Figure 2C</bold></xref>
###xml 243 252 243 252 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2D</bold>
###xml 243 252 243 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g002"><bold>Figure 2D</bold></xref>
###xml 444 453 444 453 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2E</bold>
###xml 444 453 444 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g002"><bold>Figure 2E</bold></xref>
To fully characterize DJ-1 silencing by siRNA-B 100 nM, we performed a time-course experiment, shown in [Figure 2C]. DJ-1 protein level significantly decreased starting from 72 h and this reduction was even more evident at 96h, as reported in Figure 2D. DJ-1 downregulation at 72 h after siRNA treatment was also independently confirmed by immunocytochemistry, where a decrease of DJ-1 immunostaining was found in the DJ-1 siRNA treated-cells [Figure 2E].
###end p 49
###begin p 50
###xml 237 238 237 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 239 240 239 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 353 354 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 355 356 355 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 547 556 547 556 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2F</bold>
###xml 547 556 547 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g002"><bold>Figure 2F</bold></xref>
Then, we challenged cells with the oxidative agent 72 h after DJ-1 silencing, in order to be sure to achieve DJ-1 downregulation in a detectable way. In this condition, SK-N-BE cells were more susceptible to oxidative damage induced by H2O2 or 6-OHDA, with a strong reduction in cellular viability that dropped under 25% in comparison to control after H2O2 and under 50% after 6-OHDA. This effect was specifically due to DJ-1 silencing, as the treatment with a siRNA negative control (CT-) did not influence the cell response to oxidative stress [Figure 2F].
###end p 50
###begin p 51
###xml 445 446 441 442 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 447 448 443 444 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 665 674 657 666 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2G</bold>
###xml 665 674 657 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g002"><bold>Figure 2G</bold></xref>
###xml 854 864 846 856 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1A</bold>
###xml 854 864 846 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001884.s001"><bold>Figure S1A</bold></xref>
To further check the specificity of this DJ-1-silencing effect, we tried to reverse the DJ-1 silencing by adding TAT-DJ-1 3 microM 2h before the oxidative treatment. We were able to reproduce the deleterious effect of DJ-1 silencing (as cell viability of the silenced groups in presence of oxidative stress was decreased in comparison to DJ-1 not silenced groups), and when we added TAT-DJ-1 this completely counteracted the negative effect of H2O2 or 6-OHDA. The extracellular add of 3 microM recombinant DJ-1 (a purified form of DJ-1 without the TAT sequence) had no such effect, confirming that only TAT-DJ-1 entered the plasma membrane and protected the cells [Figure 2G]. We found the same situation when we treated cells with a TAT-GFP fusion protein that entered inside cells but was unable to counteract the deleterious effect of DJ-1 silencing (Figure S1A).
###end p 51
###begin title 52
DJ-1 silencing prevents TAT-alpha-syn protective action and increases TAT-alpha-syn dose-dependent toxicity
###end title 52
###begin p 53
###xml 164 165 156 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 166 167 158 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 191 200 183 192 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A</bold>
###xml 191 200 183 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g003"><bold>Figure 3A</bold></xref>
###xml 259 260 247 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 261 262 249 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 466 467 454 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 468 469 456 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 798 807 782 791 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3B</bold>
###xml 798 807 782 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g003"><bold>Figure 3B</bold></xref>
To explore a possible functional relationship between DJ-1 and alpha-syn we silenced DJ-1 expression by siRNA and tested TAT-alpha-syn mediated protection against H2O2 or 6-OHDA. As shown in Figure 3A, TAT-alpha-syn at nanomolar scale completely antagonized H2O2 or 6-OHDA toxicity, but this effect was no longer detectable in the presence of DJ-1 downregulation by siRNA. In this situation, cell viability dropped to under 50%, whit a more pronounced toxicity for H2O2 treatment. This effect was specifically dependent on DJ-1 inactivation, as TAT-alpha-syn maintained almost unchanged its protective effect against oxidative stress in the presence of a siRNA negative control (CT-) and when the DJ-1 protein level was restored by exogenous addition of TAT-DJ-1 2h before the oxidative challenge [Figure 3B].
###end p 53
###begin title 54
DJ-1 silencing prevents TAT-alpha-syn protective action and increases its dose-dependent toxicity.
###end title 54
###begin p 55
###xml 353 361 341 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 789 797 769 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 1180 1188 1130 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
(A) Cells were pre-incubated with TAT-alpha-syn 0.5 microM for 2 h. Then, the oxidative stimuli were added for a further 24 h. In the DJ-1 silenced group, before TAT-alpha-syn treatment, DJ-1 expression was silenced for 72 h. Cell viability was assessed by erythrosine-dye exclusion assay; **p<0.01 vs control group (siRNA lipid vehicle alone), Tukey's post-hoc test. (B) Cells were incubated with siRNA negative control (CT-) or with DJ-1 siRNA for 72 h. Then, in the DJ-1 siRNA cells, TAT-DJ-1 3 microM was added to culture medium and after 2 h TAT-alpha-syn was added to the indicated groups. After 2 h, the oxidative challenge was then carried out for 24 h. Cell viability was assessed by erythrosine-dye exclusion assay. **p<0.01 vs control group (siRNA lipid vehicle alone), Tukey's post-hoc test; #p<0.01, two-way ANOVA for TAT-alpha-syn (x) TAT-DJ-1. (C) Cells were silenced for DJ-1 expression for 72 h, then TAT-alpha-syn 0.5 microM was added for 24 h. In the TAT-DJ-1 group, TAT-DJ-1 was added to the culture medium 2 h before TAT-alpha-syn. CT-: siRNA negative control; **p<0.01 vs control group (no TAT-alpha-syn added); degreesp<0.05 vs TAT-alpha-syn alone; Tukey's post-hoc test; #p<0.01, two-way ANOVA for TAT-alpha-syn (x) TAT-DJ-1. (D) Western blot showing TAT-alpha-syn higher-molecular-weight immunoreactive bands after DJ-1 silencing. Cells were silenced for DJ-1 expression for 72 h, after that TAT-alpha-syn 0.5 microM was added for 24 h. Cell lysates were subjected to gradient SDS-PAGE (5-12%). The arrow indicates the monomeric form of TAT-alpha-syn around 20 KDa, while the bracket the presence of higher-molecular-weight immunoreactivity. Also alpha-tubulin immunoreactivity is shown to demonstrate equal gel loading.
###end p 55
###begin p 56
###xml 354 363 342 351 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3C</bold>
###xml 354 363 342 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g003"><bold>Figure 3C</bold></xref>
We noticed another relevant effect of DJ-1 silencing on TAT-alpha-syn. In fact, after DJ-1 silencing by siRNA, if TAT-alpha-syn was added to cells at 0.5 microM for 24 h, it not only lost its protective property against oxidative stress but also became toxic in absence of a deleterious stimulus, triggering by itself cell death in a significant manner [Figure 3C]. To confirm that this effect was specifically due to DJ-1 silencing we tried a reversion by addition of TAT-DJ-1. In this context, TAT-alpha-syn was no more toxic, a situation that was replicated when instead of DJ-1 siRNA we used a no-match siRNA negative control (CT-).
###end p 56
###begin p 57
###xml 356 365 336 345 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3D</bold>
###xml 356 365 336 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g003"><bold>Figure 3D</bold></xref>
The following step was to assess whether DJ-1 silencing caused TAT-alpha-syn 0.5 microM toxicity by modulation of its aggregation state and if DJ-1 silencing affected total TAT-alpha-syn availability inside cells. To this purpose, we used Western blotting to detect TAT-alpha-syn aggregates and to quantify intracellular available monomeric TAT-alpha-syn [Figure 3D]. Only when cells were treated with DJ-1 siRNA we noticed the appearance of higher-molecular-weight alpha-syn immunoreactive bands (around 40-50 KDa), suggesting of TAT-alpha-syn aggregation. On the contrary, in presence of siRNA lipid vehicle alone only the monomeric alpha-syn band around 20 KDa was detectable. Remarkably, Western blotting quantification data supported a statistically significant increase of about 25% of intracellular total monomeric TAT-alpha-syn in presence of DJ-1 siRNA [monomeric TAT-alpha-syn/alpha-tubulin OD ratio for siRNA lipid vehicle (mean+/-SD, n = 4): 2.4+/-0.2 ; monomeric TAT-alpha-syn/alpha-tubulin OD ratio for DJ-1 siRNA (mean+/-SD, n = 4): 3.0+/-0.2, p<0.02, Student's t-test].
###end p 57
###begin p 58
###xml 276 285 264 273 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1G</bold>
###xml 276 285 264 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g001"><bold>Figure 1G</bold></xref>
We also tried to independently confirm TAT-alpha-syn 0.5 microM amyloid aggregation in presence of DJ-1 siRNA by thioflavin-T staining. However, we did not find any positive signal (data not shown), even if this method was able to clearly detect TAT-alpha-syn aggregates [see Figure 1G].
###end p 58
###begin p 59
###xml 143 144 135 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 145 146 137 138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 406 407 378 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 408 409 380 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 558 568 526 536 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1B</bold>
###xml 558 568 526 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001884.s001"><bold>Figure S1B</bold></xref>
We have also verified an alternative scenario where we tried to trigger TAT-alpha-syn 0.5 microM neurotoxicity in SK-N-BE cells by increasing H2O2 amount (raised to 100 microM) and 6-OHDA amount (raised to 75 microM) for 24h in order to mimic an increase of oxidative stress due to DJ-1 depletion. No evident additive toxic effect of TAT-alpha-syn was assessed in presence of TAT-alpha-syn 0.5 microM and H2O2 or 6-OHDA. On the contrary, in 6-OHDA treated cells a weak but statistically significant neuroprotective action of TAT-alpha-syn was still present (Figure S1B).
###end p 59
###begin title 60
TAT-DJ-1 affects HSP70 mRNA expression
###end title 60
###begin p 61
###xml 128 132 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Albani1">[36]</xref>
###xml 391 400 387 396 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 391 400 387 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g004"><bold>Figure 4A</bold></xref>
###xml 565 574 561 570 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 565 574 561 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g004"><bold>Figure 4B</bold></xref>
Previous data suggested that the protective action of TAT-alpha-syn against oxidative stress involved an up-regulation of HSP70 [36]. In order to find out whether HSP70 was also involved in the DJ-1-mediated antioxidant response, we assessed the effect on HSP70 expression of TAT-DJ-1 and DJ-1 silencing by semiquantitative RT-PCR, using aldolase A (GenBank NM_184041) as internal standard [Figure 4A]. In the presence of TAT-DJ-1, HSP70 mRNA was about 2.5 times control, and this increase was statistically significant as reported in the gel quantification graph [Figure 4B]. Instead, the DJ-1 siRNA treatment or the siRNA negative control (CT-) treatment had no such effect on HSP70 expression that was similar to the basal level.
###end p 61
###begin title 62
TAT-DJ-1 affects HSP70 mRNA expression.
###end title 62
###begin p 63
###xml 458 459 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 567 575 567 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
###xml 901 902 897 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 989 997 985 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
A) Digital image of a capillary electrophoresis assessing the effect of DJ-1 on HSP70 mRNA expression. Cells were either incubated with TAT-DJ-1 for 24 h or silenced for DJ-1 expression for 72 h. Then total mRNA was extracted, reverse-transcribed and amplified to detect HSP70 (550 bp band) and aldolase-A (180 bp band), used as internal control. The bar graph (B) shows the RT-PCR assay values and is representative of one of three independent experiments (n = 4 for each group). CT-: siRNA negative control; **p<0.01 vs control (siRNA lipid vehicle alone), Tukey's post-hoc test. (C) Western blot showing HSP70 protein expression. Cells were incubated with either TAT-DJ-1 for 24h or DJ-1 siRNA for 72 h, then harvested for Western blotting. The bar graph (D) shows the calculated values normalized to alpha-tubulin as internal control and is representative of one of three independent experiments (n = 3 for each group); ***p<0.001 vs control group (siRNA lipid vehicle alone), Tukey's post-hoc test. (E) Western blotting assessing HSP70 expression level in SK-N-BE cells incubated with negative control TAT-fused proteins. Cells were incubated with TAT-GFP or TAT-alpha-syn(1-97) for 24 h and then harvested to perform HSP70 immunodetection.
###end p 63
###begin p 64
###xml 122 131 122 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4C</bold>
###xml 122 131 122 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g004"><bold>Figure 4C</bold></xref>
###xml 332 341 332 341 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4D</bold>
###xml 332 341 332 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g004"><bold>Figure 4D</bold></xref>
Then, we decided to confirm by Western blotting if HSP70 mRNA increase was also detectable at protein level. As shown in [Figure 4C], in the presence of TAT-DJ-1 the HSP70 immunoreactive band increased about 2 times the control level, and this increase was statistically significant as assessed by the blot quantification reported [Figure 4D]. However, HSP70 protein level kept unchanged after DJ-1 siRNA treatment, whose effect on its target was clearly detectable as the DJ-1 immunoreactive band was about half the control, with a statistically significant reduction of about 50%. The increase of DJ-1 protein level due to TAT-DJ-1 addition was also evident, with a statistically significant increase of DJ-1 immunoreactive band of about 1.5 times the basal level.
###end p 64
###begin p 65
###xml 413 417 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Albani1">[36]</xref>
###xml 418 427 410 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4E</bold>
###xml 418 427 410 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g004"><bold>Figure 4E</bold></xref>
These TAT-DJ-1 mediated effect on HSP70 expression was specific, as when we used an unrelated TAT-GFP fusion protein no HSP70 increase at protein level was detectable. A similar pattern was obtained using another TAT-fused control protein represented by TAT-alpha-syn(1-97), a C-terminal truncated alpha-syn form that we previously showed to enter plasma membrane but was unable to induce HSP70 in PC12 cell line [36][Figure 4E].
###end p 65
###begin p 66
###xml 299 303 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Albani1">[36]</xref>
###xml 340 349 328 337 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5A</bold>
###xml 340 349 328 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g005"><bold>Figure 5A</bold></xref>
###xml 580 589 560 569 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5B</bold>
###xml 580 589 560 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g005"><bold>Figure 5B</bold></xref>
###xml 825 834 793 802 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3D</bold>
###xml 825 834 793 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g003"><bold>Figure 3D</bold></xref>
###xml 905 914 873 882 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5B</bold>
###xml 905 914 873 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g005"><bold>Figure 5B</bold></xref>
Finally, to verify whether DJ-1-dependent HSP70 upregulation was relevant for TAT-alpha-syn protective action, we performed an experiment where DJ-1 was downregulated by siRNA approach and cells where incubated with TAT-alpha-syn 0.5 microM, a neuroprotective condition involving HSP70 upregulation [36]. As assessed by Western blotting in Figure 5A, when we treated cells with TAT-alpha-syn 0.5 microM alone for 24h we confirmed an increase of HSP70 expression of about 40% the basal level. This effect was statistically significant as reported in the blot quantification graph [Figure 5B]. On the contrary, when TAT-alpha-syn 0.5 microM was added to cells for 24 h after a 72 h DJ-1 silencing, HSP70 increase was no more detectable and an increase of total intracellular monomeric TAT-alpha-syn was confirmed in analogy to Figure 3D (DJ-1 silencing was effective, as confirmed by blot quantification in Figure 5B). We were also able to restore HSP70 upregulation by adding TAT-DJ-1 3 microM before TAT-alpha-syn 0.5 microM incubation in SK-N-BE cells silenced for DJ-1 expression (data not shown).
###end p 66
###begin title 67
DJ-1 silencing prevents TAT-alpha-syn-mediated HSP70 upregulation.
###end title 67
###begin p 68
###xml 363 364 347 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 450 458 434 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">post-hoc</italic>
(A) In the DJ-1 silenced group, SK-N-BE cells were silenced for DJ-1 expression for 72 h, TAT-alpha-syn 0.5 microM was then added for 24 h and finally cells were harvested for Western blotting to assess HSP70, DJ-1 and TAT-alpha-syn immunoreactivity. The graph (B) shows blot quantification for HSP70 and DJ-1 expression using alpha-tubulin as internal standard (n = 3 for each group); **p<0.01, vs control group (siRNA lipid vehicle alone), Tukey's post-hoc test.
###end p 68
###begin p 69
###xml 277 287 265 275 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1C</bold>
###xml 277 287 265 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001884.s001"><bold>Figure S1C</bold></xref>
Finally, we verified whether TAT-alpha-syn 0.5 microM was able to induce DJ-1 upregulation at protein level, an effect that could in turn promote HSP70 expression. We were unable to find out a DJ-1 increase at protein level when we incubated cells with TAT-alpha-syn for 24 h (Figure S1C).
###end p 69
###begin title 70
Discussion
###end title 70
###begin p 71
We analyzed a possible functional relationship between DJ-1 and alpha-syn in a cellular model of oxidative stress, a detrimental condition that is believed to play a major role in neurodegenerative disorders. Both proteins have been linked to familial early-onset forms of PD, but it is still not clear why pathogenic mutations in these two apparently unrelated molecules lead ultimately to the same clinical features.
###end p 71
###begin p 72
###xml 377 378 377 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 379 380 379 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
DJ-1 role was investigated after increasing its intracellular expression level by exogenous addition of a TAT-fused recombinant protein, while its expression was downregulated by siRNA. These experiments outlined a major role of DJ-1 in the antioxidant response, as its overexpression correlated positively with a survival outcome. This protective function was not limited to H2O2 challenge but was also clear against 6-OHDA, a neurotoxin whose noxious effect reproduces what happens in the dopamine-selective environment of PD neurodegeneration. Moreover, the antioxidant effect was specific, as neither a recombinant DJ-1 without the TAT fused-sequence (that was consequently unable to enter the cell) nor a siRNA negative control (that did not affect the level of DJ-1 mRNA) prevented the oxidative damage. Starting from these data, it is reasonable to conclude that one effect of DJ-1 inactivation by genetic alterations is to impair its prevention of oxidative stress, thus exposing dopaminergic neurons to exogenous or endogenous deleterious stimuli.
###end p 72
###begin p 73
###xml 291 295 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Zhou2">[33]</xref>
Zhou et al. suggested that DJ-1-mediated protective action against alpha-syn (A53T) overexpression ant toxicity involved HSP70 up-regulation, but this mechanism was not reported under oxidative stress conditions where a DJ-1-dependent increase of glutathione cellular levels was highlighted [33]. We found an increase of HSP70 both at mRNA and protein level after DJ-1 overexpression obtained by adding TAT-DJ-1. This effect missed using TAT-GFP or TAT-alpha-syn(1-97) fusion proteins, suggesting that HSP70 increase was not solely due to a generic cell response to molecular crowding after TAT-mediated protein delivery. HSP70 upregulation might mediate also TAT-DJ-1 antioxidant action, even if in our experiments under oxidative stress condition we have not directly demonstrate this aspect. Moreover, our data do not rule out the possible involvement of other DJ-1-mediated antioxidant mechanisms, like glutathione increase.
###end p 73
###begin p 74
###xml 122 123 118 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 124 125 120 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 178 182 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Albani1">[36]</xref>
###xml 86 89 <span type="species:ncbi:10116">rat</span>
We have already demonstrated an antioxidant function of TAT-administered alpha-syn in rat PC12 cells, where it prevented H2O2 oxidative damage by raising the HSP70 protein level [36]. Here, we have extended this protective property to 6-OHDA, providing evidence that alpha-syn is an important neuroprotective element whose deficiency due to aggregation may concur in triggering PD.
###end p 74
###begin p 75
An important issue addressed by our experiments was the possible functional relationship between DJ-1 and alpha-syn, in order to verify whether they do indeed belong to the same antioxidant pathway. When we downregulated DJ-1 expression by siRNA, TAT-alpha-syn alone was no longer able to protect cells from the oxidative damage, suggesting that DJ-1 presence is needed for an efficient antioxidant response, probably as a consequence of its positive action on HSP70 expression. So, when DJ-1 is inactivated this condition is deleterious not only directly but also indirectly as it negatively affects a second cell-protective mechanism based on alpha-syn neuroprotective function.
###end p 75
###begin p 76
A second, unexpected but relevant consequence of DJ-1 downregulation on TAT-alpha-syn was that in this situation TAT-alpha-syn was not only unable to counteract the oxidative challenge but it became toxic by itself even in the absence of oxidative stress and starting from nanomolar intracellular concentration that was usually protective. As alpha-syn toxicity is generally considered a consequence of its aggregation, we verified that when TAT-alpha-syn had deleterious properties an aggregation pattern was detectable. In fact, only in the presence of DJ-1 siRNA we were able to identify TAT-alpha-syn oligomeric aggregates by Western blotting. This DJ-1 effect on TAT-alpha-syn nanomolar toxicity was specific as it could not be reproduced by recombinant DJ-1 (a purified form of DJ-1 without the TAT sequence) or siRNA negative control and was reversed by addition of TAT-DJ-1 after DJ-1 silencing. Moreover, when DJ-1 was silenced, TAT-alpha-syn at nanomolar scale was unable to induce HSP70 upregulation, an aspect that might contribute to TAT-alpha-syn aggregation and toxicity. A clear molecular mechanism leading to TAT-alpha-syn aggregation in presence of DJ-1 silencing by siRNA is not evident by our experiments. We can rule out that TAT-alpha-syn toxicity was just a consequence of increased oxidative stress after DJ-1 downregulation as an increased oxidative insult was unable to trigger TAT-alpha-syn 0.5 microM toxicity, thus suggesting that DJ-1 directly modulated alpha-syn aggregation properties. However, considering our data reporting an increased monomeric TAT-alpha-syn availability inside cells in presence of DJ-1 siRNA, we can suggest that DJ-1 downregulation might negatively affect TAT-alpha-syn degradation pathway, with a consequent TAT-alpha-syn accumulation that can promote its self-aggregation. So, in the presence of a reduced amount of DJ-1 TAT-alpha-syn aggregation can start at a nanomolar scale that is normally protective and too low to trigger aggregation by itself.
###end p 76
###begin p 77
###xml 473 477 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Zhou2">[33]</xref>
The fact that in the same condition we were unable to detect any amyloid-like aggregates by thioflavin-T staining might depend on the extent of alpha-syn aggregation. In fact, the formation of alpha-syn immunoreactive bands was limited to molecular weights 40-50 KDa, with no higher-molecular-weight oligomers, suggesting that larger amyloid fibrils probably require a more concentrated TAT-alpha-syn starting substrate. In accordance with this interpretation, Zhou et al. [33] did find higher-molecular-weight alpha-syn [A53T] aggregates but after strong alpha-syn overexpression due to adenoviral infection. However, even without large alpha-syn amyloid aggregates cell toxicity was evident, in agreement with the hypothesis that the early step of alpha-syn fibril formation is responsible for its toxicity.
###end p 77
###begin p 78
###xml 270 274 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Zhou3">[38]</xref>
In relation to PD pathogenesis, an inactivating DJ-1 genetic alteration might first of all prevent its direct antioxidant action but it might be also important in promoting alpha-syn aggregation and the related toxicity, that is accelerated by a pro-oxidant environment [38].
###end p 78
###begin p 79
###xml 41 49 41 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6</bold>
###xml 41 49 41 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001884-g006"><bold>Figure 6</bold></xref>
###xml 125 126 121 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 127 128 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 813 817 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Albani1">[36]</xref>
In summary, as schematically depicted in Figure 6, DJ-1 and alpha-syn are both involved in the antioxidant response against H2O2 and 6-OHDA and HSP70 is a common downstream mediator of the antioxidant properties of these two proteins. A direct mechanistic relationship between alpha-syn, DJ-1 and HSP70 is not supported by our data. In fact, TAT-alpha-syn was able to increase HSP70 level in presence of DJ-1 but TAT-alpha-syn was unable to increase DJ-1 expression that could in turn promote HSP70 upregulation. A possible interpretation could be that DJ-1 and alpha-syn promote HSP70 upregulation but at different levels. In fact, TAT-DJ-1 addition increased HSP70 at mRNA and protein expression level, at difference from TAT-alpha-syn that was unable to modulate HSP70 mRNA, as we have previously demonstrated [36]. So, it might happen that TAT-alpha-syn increases HSP70 protein level by a chaperone-like stabilization mechanism or by an action that reduces HSP70 degradation over time. This might also explain why in absence of DJ-1 TAT-alpha-syn was unable to increase HSP70 at protein level. In fact, when DJ-1 was downregulated TAT-alpha-syn formed insoluble aggregates and in this aggregated form it is likely that it was unable to interact with HSP70 and stabilize it. More importantly, we showed that DJ-1 expression is relevant not only for the effect on HSP70 but also in controlling alpha-syn function which, when there are only small amounts of DJ-1, is shifted from a soluble, neuroprotective condition to an aggregated, neurotoxic context.
###end p 79
###begin title 80
Schematic representation of the neuroprotective network against oxidative stress mediated by alpha-synuclein (alpha-syn) and DJ-1.
###end title 80
###begin p 81
###xml 280 293 257 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper pathway</italic>
###xml 827 840 784 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower pathway</italic>
###xml 957 961 910 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Albani1">[36]</xref>
###xml 1167 1171 1112 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001884-Zhou2">[33]</xref>
Red arrows identify noxious molecular events, while green arrows trace pro-survival cellular mechanisms. The symbol middle dot in circle stands for "antagonizes". The free, soluble form of alpha-syn can be committed to aggregation and the related toxicity by DJ-1 downregulation (upper pathway), maybe through alpha-syn impaired degradation. In this situation, cell response to oxidative stress is impaired by DJ-1 deficiency, but also by alpha-syn aggregation-dependent indirect toxicity that prevents the protein neuroprotective role and stops alpha-syn-mediated HSP70 upregulation at protein level. In addition, alpha-syn aggregation has a direct toxic effect, probably pro-oxidant, that increases cell damage and triggers a positive feedback loop that promotes further alpha-syn aggregation. In non-aggregating conditions (lower pathway), in the presence of oxidative stress alpha-syn promotes cell survival and HSP70 up-regulation (Albani et al., 2004 [36]). In this situation, wild type DJ-1 contributes to keep alpha-syn in the soluble form. HSP70 is also a downstream molecular target of DJ-1, that increases HSP70 expression preventing alpha-syn aggregation [33]. DJ-1 pathogenic mutations might impair this function, leading to cell damage through the upper pathway.
###end p 81
###begin p 82
In conclusion, DJ-1 and HSP70 might be therapeutic targets in PD for their role in counteracting oxidative stress and their involvement in alpha-syn solubility-related cell function.
###end p 82
###begin title 83
Supporting Information
###end title 83
###begin p 84
(9.17 MB TIF)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
We are grateful to J. D. Baggott for English editing.
###end p 86
###begin title 87
References
###end title 87
###begin article-title 88
The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?
###end article-title 88
###begin article-title 89
Description of Parkinson's disease as a clinical syndrome.
###end article-title 89
###begin article-title 90
Genes and parkinsonism.
###end article-title 90
###begin article-title 91
Parkinson's disease: the genetics of a heterogeneous disorder.
###end article-title 91
###begin article-title 92
The genetics of Parkinson disease: Implications for neurological care.
###end article-title 92
###begin article-title 93
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
###end article-title 93
###begin article-title 94
Ala30-to-pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
###end article-title 94
###begin article-title 95
Parkinsonism genes: culprits and clues.
###end article-title 95
###begin article-title 96
Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease.
###end article-title 96
###begin article-title 97
The morphological basis of mental dysfunction in Parkinson's disease.
###end article-title 97
###begin article-title 98
Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease.
###end article-title 98
###begin article-title 99
Detection of novel intracellular alpha-synuclein oligomeric species by fluorescence lifetime imaging.
###end article-title 99
###begin article-title 100
Transgenic models of alpha-synuclein pathology: past, present, and future.
###end article-title 100
###begin article-title 101
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
Genetic mouse models of parkinsonism: strengths and limitations
###end article-title 101
###begin article-title 102
alpha-Synuclein locus triplication causes Parkinson's disease.
###end article-title 102
###begin article-title 103
Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.
###end article-title 103
###begin article-title 104
Alpha-synuclein and presynaptic function: implications for Parkinson's disease.
###end article-title 104
###begin article-title 105
Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity.
###end article-title 105
###begin article-title 106
Chaperone-like activities of alpha-synuclein: alpha-synuclein assists enzyme activities of esterases.
###end article-title 106
###begin article-title 107
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions.
###end article-title 107
###begin article-title 108
Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease.
###end article-title 108
###begin article-title 109
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease.
###end article-title 109
###begin article-title 110
Assessment of a DJ-1 (PARK7) polymorphism in Finnish PD
###end article-title 110
###begin article-title 111
Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases.
###end article-title 111
###begin article-title 112
###xml 9 19 <span type="species:ncbi:7227">Drosophila</span>
Roles of Drosophila DJ-1 in survival of dopaminergic neurons and oxidative stress.
###end article-title 112
###begin article-title 113
###xml 16 26 <span type="species:ncbi:7227">Drosophila</span>
Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.
###end article-title 113
###begin article-title 114
DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation.
###end article-title 114
###begin article-title 115
The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein.
###end article-title 115
###begin article-title 116
###xml 131 153 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans.
###end article-title 116
###begin article-title 117
Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis.
###end article-title 117
###begin article-title 118
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1.
###end article-title 118
###begin article-title 119
###xml 40 45 <span type="species:ncbi:9606">human</span>
DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor.
###end article-title 119
###begin article-title 120
DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity.
###end article-title 120
###begin article-title 121
Heat Shock Protein 70 Inhibits alpha-Synuclein Fibril Formation via Interactions with Diverse Intermediates.
###end article-title 121
###begin article-title 122
Hsp70 Reduces alpha-Synuclein Aggregation and Toxicity.
###end article-title 122
###begin article-title 123
Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70.
###end article-title 123
###begin article-title 124
###xml 58 63 <span type="species:ncbi:9796">horse</span>
Delivery of bioactive molecules into the cell: the Trojan horse approach.
###end article-title 124
###begin article-title 125
###xml 37 42 <span type="species:ncbi:9606">human</span>
Tyrosine-to-cysteine modification of human alpha-synuclein enhances protein aggregation and cellular toxicity.
###end article-title 125
###begin p 126
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 126
###begin p 127
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the public grant N.530/F-A13 from Italian Istituto Superiore di Sanita. L.P. is recipient of a Cenci-Gallingani Foundation post-graduate fellowship.
###end p 127

